Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

BACKGROUND/AIMS: The dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kim, Hyeyoung, Yi, Nam-Joon, Lee, Juyeun, Kim, Joohyun, Moon, Mi-Ra, Jeong, Jaehong, Lee, Jeong-Moo, You, Tae Suk, Suh, Suk-Won, Park, Min-Su, Choi, YoungRok, Hong, Geun, Lee, Hae Won, Lee, Kwang-Woong, Suh, Kyung-Suk
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association for the Study of the Liver 2014
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4197178/
https://ncbi.nlm.nih.gov/pubmed/25320733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.3.291
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak